Table 2 Clinicopathological baseline characteristics of included patients with gynecological uterine sarcomas
From: Management of uterine sarcomas and prognostic indicators: real world data from a single-institution
Number of patients | 61 |
Age (years) | |
 Median | 53 |
 below 65 | 52 (85.25%) |
 over 65 | 9 (14.75%) |
Histology | |
 LMS | 51 (83.61%) |
 ESS | 3 (4.92%) |
 UUS | 5 (8.20%) |
 ES | 1 (1.64%) |
 RS | 1 (1.64%) |
Tumor size | |
  < 10 cm | 16 (26.23%) |
  > 10 cm | 45 (73.77%) |
Grade | |
 Grade 1 | 3 (4.92%) |
 Grade 2 | 6 (9.84%) |
 Grade 3 | 50 (81.97%) |
FIGO Stage | |
 Stage I | 24 (39.34%) |
 Stage II | 7 (18.03%) |
 Stage III | 14(22.95%) |
 Stage IV | 16 (26.23%) |
Mitotic index | |
 Mitosis < 15 per HPF | 25/47 (53.19%) |
 Mitosis > 15 per HPF | 22/47 (46.81%) |